SB 234551 selective ETA receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection-Reference-Cited by-同舟云学术

SB 234551 selective ETA receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection

Published:2008-07 Issue:1 Volume:212 Page:53-62
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Legos Jeffrey J.,Lenhard Stephen C.,Haimbach Robin E.,Schaeffer Thomas R.,Bentley Ross G.,McVey Matthew J.,Chandra Sudeep,Irving Elaine A.,Andrew A. Parsons ,Barone Frank C.

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference80 articles.

1. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection;Albers;Stroke.,1999

2. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study;Albers;Ann. Neurol.,2006

3. Evaluation of plasma endothelin-1 levels in patients with cerebral infarction;Alioglu;Angiology,2002

4. Perfusion and diffusion imaging in acute focal cerebral ischemia: temporal vs. spatial resolution;Bardutzky;Brain Res.,2005

5. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging;Bardutzky;Stroke,2005

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelin Receptors in Cerebrovascular Diseases;GPCRs as Therapeutic Targets;2022-09-16

2. The Role of ET-1 in Early Cerebral Microcirculation Changes after Subarachnoid Hemorrhage;Journal of Healthcare Engineering;2022-04-11

3. Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders;International Journal of Molecular Sciences;2022-03-15

4. Thomas Willis Lecture;Stroke;2021-07

5. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke;CNS Drugs;2021-01